Wendy S. Johnson is Director of EXAGEN INC.. Currently has a direct ownership of 1,000 shares of XGN, which is worth approximately $2,430. The most recent transaction as insider was on Sep 03, 2021, when has been sold 1,000 shares (Common Stock) at a price of $14.02 per share, resulting in proceeds of $14,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1K
0% 3M change
0% 12M change
Total Value Held $2,430

Wendy S. Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2021
BUY
Open market or private purchase
$14,020 $14.02 p/Share
1,000 Added 50.0%
1,000 Common Stock

Also insider at

RPHM
Reneo Pharmaceuticals, Inc. Healthcare
WSJ

Wendy S. Johnson

Director
Vista, CA

Track Institutional and Insider Activities on XGN

Follow EXAGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XGN shares.

Notify only if

Insider Trading

Get notified when an Exagen Inc. insider buys or sells XGN shares.

Notify only if

News

Receive news related to EXAGEN INC.

Track Activities on XGN